Key Insights

Highlights

Success Rate

99% trial completion (above average)

Research Maturity

83 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.7%

1 terminated out of 144 trials

Success Rate

98.8%

+12.3% vs benchmark

Late-Stage Pipeline

25%

36 trials in Phase 3/4

Results Transparency

8%

7 of 83 completed with results

Key Signals

7 with results99% success

Data Visualizations

Phase Distribution

97Total
Not Applicable (37)
P 1 (5)
P 2 (19)
P 3 (21)
P 4 (15)

Trial Status

Completed83
Unknown24
Recruiting17
Not Yet Recruiting11
Active Not Recruiting3
Withdrawn3

Trial Success Rate

98.8%

Benchmark: 86.5%

Based on 83 completed trials

Clinical Trials (144)

Showing 20 of 20 trials
NCT07733635Not Yet RecruitingPrimary

Vitamin D Status and Asthma Control, Pulmonary Function, and Oxidative Stress in Adults With Bronchial Asthma

NCT06427876Active Not RecruitingPrimary

Fasenra Pediatric Japan Post-Marketing Study(PMS)

NCT07703358Not ApplicableNot Yet Recruiting

Effect of Chromium Weight Reduction on Adult Asthma Control

NCT00242307Phase 2CompletedPrimary

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05).

NCT00246922Phase 3CompletedPrimary

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07).

NCT07632352Not ApplicableRecruitingPrimary

Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma

NCT07620691Not ApplicableRecruitingPrimary

N95 Masks for Lung Health While Golfing During Wildfire Season

NCT04157361RecruitingPrimary

Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.

NCT04613245Completed

Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19

NCT07326995Phase 2RecruitingPrimary

Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma

NCT07324707Phase 2RecruitingPrimary

Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma

NCT06916273Phase 1CompletedPrimary

Safety, Tolerability, and Pharmacokinetics of PA9159 Inhalation Aerosol in Healthy Adult Subjects

NCT07273500Not ApplicableCompletedPrimary

Precision Exercise in Obese Children With Bronchial Asthma

NCT07231861Phase 1Not Yet RecruitingPrimary

Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers

NCT07230912Not Yet RecruitingPrimary

Impact of Comorbidities, Some Biomarkers, Micro RNA in Childhood Asthma Phenotypes

NCT07183657Not ApplicableRecruiting

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

NCT07154355Not ApplicableRecruiting

Community Exercise Treating Effect on Cardiopulmonary Disease Patients

NCT06721247Phase 2Active Not RecruitingPrimary

Oral Intake of Mg in Controlled Asthmatic Patients

NCT06154304Phase 3CompletedPrimary

BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma

NCT07060079RecruitingPrimary

The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease

Scroll to load more

Research Network

Activity Timeline